Pancreatic Cases GLP-1 medications have been associated with pancreatitis, an inflammation of the pancreas
Tirzepatide is administered as a subcutaneous injection, meaning it goes into the fatty tissue just under the skin, rather than into a muscle or vein
Hashimoto's thyroiditis is not listed as a contraindication to Wegovy treatment in the current Summary of Product Characteristics (SmPC) approved by the MHRA
When dissolved in water, they can support hydration, nerve function, and muscle contraction
At this point, you should be seeing consistent weight loss of 3-5 pounds per month
When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period